Mitigating antimicrobial resistance by innovative solutions in AI (MARISA): a modified James Lind Alliance analysis
William J Waldock1, Hannah Thould1, Leonid Chindelevitch2
1Institute of Global Health Innovation, Imperial College London, London, UK.
Abstract:
Antimicrobial resistance (AMR) is a critical global health threat and artificial intelligence (AI) presents new opportunities for our response. However, research priorities at the AI-AMR intersection remain undefined. This study aimed to identify and prioritise key areas for future investigation. Using a modified James Lind Alliance approach, we conducted semi-structured interviews with eight experts in AI and AMR between February and June 2024. Analysis of 338 coded responses revealed 44 distinct themes. Major barriers included fragmented data access, integration challenges and economic disincentives. The top ten priorities identified were: Combination Therapy, Novel Therapeutics, Data Acquisition, AMR Public Health Policy, Prioritisation, Economic Resource Allocation, Diagnostics, Modelling Microbial Evolution, AMR Prediction and Surveillance. A notable limitation was the underrepresentation of data from high-burden regions, limiting the generalisability of findings. To address these gaps, we propose the novel BARDI framework: Brokered Data-sharing, AI-driven Modelling, Rapid Diagnostics, Drug Discovery and Integrated Economic Prevention.
Insights
Artificial intelligence (AI) can combat antimicrobial resistance (AMR), but research priorities are unclear. This study identified key AI-AMR research areas, including novel therapeutics and diagnostics, to guide future efforts against this global health threat.
Area of Science:
- Medical Informatics
- Infectious Diseases
- Public Health
Background:
- Antimicrobial resistance (AMR) poses a significant global health challenge.
- Artificial intelligence (AI) offers novel approaches to combat AMR, yet research priorities at this intersection are undefined.
Purpose of the Study:
- To identify and prioritize key research areas at the intersection of AI and AMR.
- To define future research directions for AI-AMR initiatives.
Main Methods:
- A modified James Lind Alliance approach was employed.
- Semi-structured interviews were conducted with eight experts in AI and AMR.
- Analysis of 338 coded responses identified 44 distinct themes.
Main Results:
- Major barriers identified include fragmented data access, integration challenges, and economic disincentives.
- Top ten research priorities include Combination Therapy, Novel Therapeutics, Data Acquisition, AMR Public Health Policy, Prioritisation, Economic Resource Allocation, Diagnostics, Modelling Microbial Evolution, AMR Prediction, and Surveillance.
- The BARDI framework (Brokered Data-sharing, AI-driven Modelling, Rapid Diagnostics, Drug Discovery, Integrated Economic Prevention) was proposed.
Conclusions:
- Defining research priorities is crucial for advancing AI applications in AMR.
- Addressing data access, economic factors, and regional representation is essential for effective AI-AMR strategies.
- The BARDI framework offers a structured approach to guide future AI-AMR research and implementation.
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...


